Quick Answer
Neurogene Inc. reported Research And Development Expense of $75.01 million for the year ending 2025.
- Neurogene Inc. showed an increase of +23.1% in Research And Development Expense from 2024 to 2025.
- This data is from Neurogene Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2012 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $573.0 thousand | Q2 2013: $1.25 million | Q3 2013: $3.03 million | Q1 2014: $1.88 million | Q2 2014: $4.55 million | Q3 2014: $5.32 million | Q1 2015: $4.57 million | Q2 2015: $3.62 million | Q3 2015: $3.69 million | Q1 2016: $4.88 million | Q2 2016: $9.24 million | Q3 2016: $6.13 million | Q1 2017: $5.78 million | Q2 2017: $10.48 million | Q3 2017: $8.46 million | Q1 2018: $10.51 million | Q2 2018: $18.00 million | Q3 2018: $10.71 million | Q1 2019: $104.0 thousand | Q1 2020: $5.50 million | Q2 2020: $4.84 million | Q3 2020: $6.22 million | Q1 2021: $9.71 million | Q2 2021: $9.82 million | Q3 2021: $9.90 million | Q1 2022: $10.70 million | Q2 2022: $10.96 million | Q3 2022: $9.47 million | Q1 2023: $10.28 million | Q2 2023: $10.32 million | Q3 2023: $11.61 million | Q1 2024: $13.54 million | Q2 2024: $15.74 million | Q3 2024: $16.29 million | Q1 2025: $17.76 million | Q2 2025: $19.37 million | Q3 2025: $17.24 million.
- Over the full 12 years of available data (2012 to 2025), Neurogene Inc.'s Research And Development Expense has grown by 1,140.8%.
- Historical annual values: Fiscal year 2025: $75.01 million | Fiscal year 2024: $60.92 million | Fiscal year 2023: $44.39 million | Fiscal year 2022: $47.51 million | Fiscal year 2021: $39.16 million | Fiscal year 2018: $41.79 million | Fiscal year 2017: $36.27 million | Fiscal year 2016: $28.38 million | Fiscal year 2015: $15.80 million | Fiscal year 2014: $18.08 million | Fiscal year 2013: $7.60 million | Fiscal year 2012: $6.05 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: